SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Kingsley Lawrence D | Director | 2026-09-04 | Option exercise | 2203 | $252K |
| Kingsley Lawrence D | Director | 2026-09-04 | Open-market sell | 2203 | $1.2M |
| Emerson Andrew | EVP, CFO and Treasurer | 2026-08-20 | Option exercise | 265 | $47K |
| Emerson Andrew | EVP, CFO and Treasurer | 2026-08-20 | Tax withholding | 86 | $0 |
| HOOLEY JOSEPH L | Director | 2026-07-30 | Grant/award | 49 | $27K |
| FENNELL GEORGE | Executive Vice President | 2026-06-01 | Option exercise | 639 | $0 |
| FENNELL GEORGE | Executive Vice President | 2026-06-01 | Tax withholding | 284 | $161K |
| HOOLEY JOSEPH L | Director | 2026-05-07 | Option exercise | 158 | $0 |
| JUNIUS DANIEL M | Director | 2026-05-07 | Option exercise | 257 | $0 |
| Kingsley Lawrence D | Director | 2026-05-07 | Option exercise | 257 | $0 |
| Kingsley Lawrence D | Director | 2026-05-07 | Option exercise | 82 | $0 |
| Peacock Karen | Director | 2026-05-07 | Option exercise | 101 | $0 |
| SZOSTAK M ANNE | Director | 2026-05-07 | Option exercise | 257 | $0 |
| Vandebroek Sophie V. | Director | 2026-05-07 | Option exercise | 257 | $0 |
| HOOLEY JOSEPH L | Director | 2026-04-30 | Grant/award | 43 | $24K |
| Hunt Nimrata | Executive Vice President | 2026-03-03 | Open-market sell | 1758 | $1.1M |
| Underberg Sharon E. | EVP, GC & Corporate Secretary | 2026-03-03 | Option exercise | 197 | $100K |
| MAZELSKY JONATHAN JAY | President and CEO, Director | 2026-02-27 | Option exercise | 197 | $100K |
| Hunt Nimrata | Executive Vice President | 2026-02-26 | Open-market sell | 2693 | $1.8M |
| MAZELSKY JONATHAN JAY | President and CEO, Director | 2026-02-26 | Option exercise | 23326 | $3.3M |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
Risk exposure broadened meaningfully across technology, governance, and compliance dimensions, with no offsetting easings. The most concrete escalation is a named CEO transition scheduled for May 2026, converting a generic succession risk into an imminent, time-bound event; simultaneously, AI risk disclosures expanded to cover operational, competitive, cybersecurity, IP, and investment dimensions, signaling a materially wider threat surface. New payment-processing and industry-standards compliance language adds specific financial consequences—fines, revenue loss, and processing disruption—that were not previously quantified.
2 company-specific · 1 common-mode
Added specific planned CEO transition in May 2026 and AI talent competition. Concrete leadership change escalates succession risk from generic to imminent.
GENERAL RISKS We depend on the efforts of key personnel and talent to succeed and compete effectively Our continued success is substantially dependent on our ability to attract, develop, and retain…
Added credit card processing exposure, industry standards compliance, and specific consequences (fines, revenue loss, payment processing disruption).
Our operations and reputation may be impaired if we, our products, or our services do not comply with our global privacy policy or evolving laws, regulations, and industry standards regarding data…
Expanded AI risk scope: now covers internal operations, competitive disadvantage, novel cybersecurity/privacy risks, IP uncertainty, and investment uncertainty—materially broadening disclosed risk exposure.
Issues in our use of AI may result in reputational harm or liability and adversely affect our business We have built, and expect to continue to build, AI into many of our product and service…
IDEXX announced its second quarter 2026 financial results on August 4, 2026, disclosing revenues of $1,217 million (10% reported growth, 9% organic), EPS of $4.27 (18% reported growth), and updated full-year 2026 guidance for revenue ($4,700–$4,745 million) and EPS ($14.69–$14.94). The full press release is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the company's financial performance and outlook.
View raw filing on EDGAR →